Article
Suppression of skin tumorigenesis in CD109-deficient mice.
Oncotarget - 13 Dec 2016
Sunagawa Masaki, Mii Shinji, Enomoto Atsushi, Kato Takuya, Murakumo Yoshiki, Shiraki Yukihiro, Asai Naoya, Asai Masato, Nagino Masato, Takahashi Masahide
Abstract excerpt
CD109 is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed in several types of human cancers, particularly squamous cell carcinomas. We previously reported that CD109-deficient mice exhibit epidermal hyperplasia and chronic skin inflammation. Although we found that CD109 regulates differentiation of keratinocytes in vivo, the function of CD109 in tumorigenesis remains unknown. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
